Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

’Smart antibiotics’ may result from UCLA research

23.09.2004


New UCLA research published in Nature may lead to an effective alternative to antibiotic drugs for treating bacterial diseases.



UCLA microbiologists report the discovery of a new class of genetic elements, similar to retroviruses, that operate in bacteria, allowing them to diversify their proteins to bind to a large variety of receptors. The team discovered this fundamental mechanism in the most abundant life?forms on Earth: bacteriophages, the viruses that infect bacteria.

"A problem with antibiotics is that bacteria can mutate and become resistant to a particular antibiotic, while the antibiotic is static and cannot change," said Jeffery F. Miller, professor and chair of microbiology, immunology and molecular genetics at UCLA, who holds UCLA’s M. Philip Davis Chair in Microbiology and Immunology, and who led the research team. "Bacteriophages ("phages") are nature’s anti-microbials, and they are amazingly dynamic. If the bacterium mutates in an effort to evade, the bacteriophage can change its specificity using the mechanism we discovered, to kill the newly resistant bacterium."


The use of bacteriophage to treat infections is not in itself a new idea. "Phage therapy has been practiced for nearly a hundred years in parts of the world, and even in the United States in the first half of the 20th century. But now, we think we can engineer bacteriophages to function as ’dynamic’ anti-microbial agents. This could provide us with a renewable resource of smart antibiotics for treating bacterial diseases," said Miller, a member of both UCLA’s David Geffen School of Medicine and the UCLA College.

"It’s a bit ironic that viruses can be used to cure bacterial diseases," said Asher Hodes, a UCLA graduate student in microbiology, immunology and molecular genetics, and a member of the research team. "This approach can be effective, especially for diseases where traditional antibiotics do not work well. There is the potential for treating bacterial infections using genetically engineered phages that will efficiently overcome bacterial resistance."

Bacteriophages evolve rapidly and are a "treasure-trove of fascinating biological mechanisms," Miller said. His research team studied a bacteriophage that was able to change to recognize different receptor molecules on the surface of bacteria. The phage genome contains a series of genes, identified by Miller’s team, that enable this fast-change routine. The researchers discovered that the phage’s genome contains a "little genetic ’cassette’ that functions to diversify the part of the virus that binds to the bacterial cell. That cassette allows the phage to rapidly evolve new variants that can recognize bacteria that may have become resistant to the previous phage," Miller said.

The microbiologists initially discovered the mechanism in a bacterial virus that infects Bordetella bronchiseptica, the "evolutionary parent" of the bacterium that causes whooping cough.

How widespread is this mechanism? Through bioinformatics and analysis of DNA sequences, Miller’s team has found evidence for many other cases where either bacteriophage or bacteria use the same strategy for targeting mutations and speeding up evolution. "We’re eager to determine how widespread it is; the more we look, the more we find it," Miller said. "And the more we study it, the more ingenious the mechanism appears to us."

In the Nature paper, the team reports the discovery of how the mechanism works to target mutations, its wide distribution in nature, and features of the mechanism that relate to applications for using it. Miller’s team is continuing to study the mechanism, to learn more about its biochemical properties, and to determine whether higher forms of life have similar cassettes. "We’re now searching the genomes of higher life forms," Miller said.

Miller believes his research team will be able to exploit the new knowledge to generate proteins in the laboratory that will bind to almost any molecule of interest. "We think we can make proteins that bind to peptides, and make peptides that bind to larger proteins," he said.

As is often the case in science, the project was initially undertaken for an unrelated reason. Minghsun Liu, a former UCLA M.D.-Ph.D. student in Miller’s laboratory, was looking for bacterial viruses to study genetics when he found a remarkable property in a particular virus. Miller’s team decided to study the phenomenon. Liu is now an infectious disease fellow at Stanford University. "This was serendipitous, nothing we ever looked for," Miller said. "Serendipity is emblematic of many discoveries in science."

The research team includes Sergei Doulatov, former UCLA undergraduate and former research associate in Miller’s laboratory; Steven Zimmerly, professor of biochemistry at the University of Calgary; graduate student Lixin Dai at the University of Calgary; Rajendar Deora, a former postdoctoral scholar in Miller’s laboratory; Neeraj Mandhana, an undergraduate student in Miller’s laboratory; and Robert Simons, UCLA associate professor of microbiology, immunology and molecular genetics. The research was funded by the National Institutes of Health.

Stuart Wolpert | EurekAlert!
Further information:
http://www.ucla.edu

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>